Skip to content

Re-feeding of children with severe acute malnutrition

Re-feeding of children hospitalized with severe acute malnutrition: an observational study from Mwanamugimu Nutrition Unit, Uganda

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN55092738
Enrollment
120
Registered
2015-09-02
Start date
2012-10-10
Completion date
Unknown
Last updated
2020-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe acute malnutrition (SAM) in children Nutritional, Metabolic, Endocrine Severe acute malnutrition (SAM)

Interventions

There was no experimental intervention. All study participants received in-patient treatment for complicated severe acute malnutrition according to standard protocols based on international guidelines

Sponsors

University of Copenhagen (Denmark)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Children between 6 - 59 months of age 2. Admitted to Mwanamugimu Nutrition Unit paediatric wards with either: 2.1 Weight for height (W/H) below the -3 standard deviations (SD) and mid upper arm circumference (MUAC) below the cut-off points for SAM 2.2. Pitting oedema developing from both feet 3. Living near the study centre

Exclusion criteria

Exclusion criteria: 1. Children with shock, severe respiratory difficulty or significant bleeding at the time of admission 2. Weight below 4.5 kg at admission 3. Very severe anaemia

Design outcomes

Primary

MeasureTime frame
Plasma phosphate was measured at five time points: on admission, the second day of treatment, the start of the transition to F-100, day two of transition and at discharge.

Secondary

MeasureTime frame
1.Blood essential fatty acids at admission, transition, discharge, 8 weeks, 16 weeks 2. Physical activity using accelerometers at discharge 3. Child development using the Malawi Development assessment tool at admission, transition, discharge, 8 weeks, 16 weeks 4. Thymus size using ultrasound at admission, discharge and week 8) 5. T-cell subsets and cytokines using flow cytometry at admission and discharge 6. Gut permeability (LM-test) at admission and discharge 7. Gut flora and pathogens at admission and discharge 8. Myocardial function and biomarkers at admission and discharge 9. Mortality during admission

Countries

Uganda

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026